Literature DB >> 3548638

Use of pattern analysis to identify true drug response. A replication.

F M Quitkin, J D Rabkin, J M Markowitz, J W Stewart, P J McGrath, W Harrison.   

Abstract

In any antidepressant study, placebo response in patients assigned active drug is a troubling source of variance. There have been few attempts to identify the patients whose conditions improve as a result of true drug effect, in contrast with improvement that is a result of nonspecific effects. In a previous report we demonstrated that true drug effect seemed to be characterized by a two-week delay in onset and persistence. We described a method of pattern analysis to identify such patients. In this report, we describe the use of pattern analysis to replicate our initial findings. Data from a new sample of 150 nonmelancholic patients support the hypothesis that true drug effect is characterized by a two-week delay in onset and persistence of improvement, once achieved. There was little evidence of the onset of antidepressant effect before two weeks. The theoretical and clinical implications of this work are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548638     DOI: 10.1001/archpsyc.1987.01800150071009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  36 in total

Review 1.  Methodology of measuring the efficacy of antidepressants.

Authors:  F M Quitkin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Time to feel good: the therapeutic time course of antidepressants.

Authors:  David Feifel
Journal:  Psychiatry (Edgmont)       Date:  2007-03

3.  Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.

Authors:  David E Kemp; Stephen J Ganocy; Martin Brecher; Berit X Carlson; Suzanne Edwards; James M Eudicone; Gary Evoniuk; Wim Jansen; Andrew C Leon; Margaret Minkwitz; Andrei Pikalov; Hans H Stassen; Armin Szegedi; Mauricio Tohen; Arjen P P Van Willigenburg; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2010-11-10       Impact factor: 4.839

4.  Partitioning of Functional Data for Understanding Heterogeneity in Psychiatric Conditions.

Authors:  Eva Petkova; Thaddeus Tarpey
Journal:  Stat Interface       Date:  2009-01-01       Impact factor: 0.582

5.  Who receives antidepressants and what impact do they have? An acute-care study.

Authors:  Patricia M Averill; Adel A Wassef
Journal:  Psychiatr Q       Date:  2006

6.  Optimal Partitioning for Linear Mixed Effects Models: Applications to Identifying Placebo Responders.

Authors:  Thaddeus Tarpey; Eva Petkova; Yimeng Lu; Usha Govindarajulu
Journal:  J Am Stat Assoc       Date:  2010-01-01       Impact factor: 5.033

Review 7.  Rapid onset of true antidepressant action.

Authors:  Matthew J Taylor
Journal:  Curr Psychiatry Rep       Date:  2007-12       Impact factor: 5.285

8.  Predicting potential placebo effect in drug treated subjects.

Authors:  Eva Petkova; Thaddeus Tarpey; Usha Govindarajulu
Journal:  Int J Biostat       Date:  2009-07-06       Impact factor: 0.968

Review 9.  Prospects for the development of new treatments with a rapid onset of action in affective disorders.

Authors:  J C Soares; S Gershon
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

10.  Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.

Authors:  Eric J Peters; Susan L Slager; Greg D Jenkins; Megan S Reinalda; Holly A Garriock; Stanley I Shyn; Jeffrey B Kraft; Patrick J McGrath; Steven P Hamilton
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.